Related Experiment Video
Updated: Jul 22, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Modeling tumor onset and multiplicity using transition models with latent variables
1Biostatistics Branch, NIEHS, Research Triangle Park, North Carolina 27709, USA. dunson1@niehs.nih.gov
This study introduces a novel statistical method for analyzing carcinogenicity in animal models, specifically using transgenic rodent data. The approach models tumor development over time, offering a robust alternative for carcinogen screening.
Area of Science:
- Toxicology and Carcinogenesis
- Biostatistics
- Animal Modeling
Background:
- Transgenic rodent studies are increasingly used for carcinogen screening as an alternative to traditional chronic bioassays.
- Skin papilloma development in transgenic mice is a common endpoint, requiring methods to analyze tumor count data over time.
Purpose of the Study:
- To develop and present a statistical modeling method for analyzing carcinogenicity data from animal studies, focusing on tumor counts over time.
- To apply this method to transgenic rodent studies for evaluating potential carcinogens.
Main Methods:
- A statistical model is proposed assuming two unobservable latent variables per animal at each time point.
- The product of these latent variables follows a zero-inflated Poisson distribution.
- The Expectation-Maximization (EM) algorithm is used to maximize the observed-data pseudo-likelihood.
- Generalized estimating equations provide a robust variance estimator to account for within-animal outcome dependency.
Main Results:
- The developed method effectively models tumor counts over time in animal carcinogenicity studies.
- It allows for the assessment of dose-related trends in both tumor incidence and multiplicity.
- The approach is validated for application in transgenic rodent screening.
Conclusions:
- The proposed statistical modeling framework provides a powerful tool for analyzing complex tumor count data in carcinogenicity studies.
- This method enhances the utility of transgenic rodent models for carcinogen screening.
- It facilitates robust statistical inference on dose-response relationships in toxicological research.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Parametric Survival Analysis: Weibull and Exponential Methods
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Exponential Equations for Modeling Growth

